×




Prayas by Sanofi-Aventis in India: Making Healthcare Accessible to the Bottom of the Pyramid Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Prayas by Sanofi-Aventis in India: Making Healthcare Accessible to the Bottom of the Pyramid case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Prayas by Sanofi-Aventis in India: Making Healthcare Accessible to the Bottom of the Pyramid case study is a Harvard Business School (HBR) case study written by Harit Palan, Anand Kumar Jaiswal, Jagdip Singh, Garima Sharma. The Prayas by Sanofi-Aventis in India: Making Healthcare Accessible to the Bottom of the Pyramid (referred as “Prayas Sanofi” from here on) case study provides evaluation & decision scenario in field of Strategy & Execution. It also touches upon business topics such as - Value proposition, Growth strategy, Marketing, Research & development.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Prayas by Sanofi-Aventis in India: Making Healthcare Accessible to the Bottom of the Pyramid Case Study


Prayas is a unique healthcare initiative, launched in India by Sanofi-Aventis, a French multinational pharmaceutical company, with the objectives of updating the medical knowledge of doctors in semi-urban and rural areas, bridging the gap between diagnosis and treatment, and making available quality medicines at affordable prices. This case discusses the evolution of the Prayas model from its inception to its current state, and the company's business strategies around it. Cognizant of the success of Prayas, many competitors of Sanofi-Aventis are actively developing and implementing similar models. The company's top management team has to respond to the competitive threat.


Case Authors : Harit Palan, Anand Kumar Jaiswal, Jagdip Singh, Garima Sharma

Topic : Strategy & Execution

Related Areas : Growth strategy, Marketing, Research & development




Calculating Net Present Value (NPV) at 6% for Prayas by Sanofi-Aventis in India: Making Healthcare Accessible to the Bottom of the Pyramid Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10022394) -10022394 - -
Year 1 3460814 -6561580 3460814 0.9434 3264919
Year 2 3961552 -2600028 7422366 0.89 3525767
Year 3 3948458 1348430 11370824 0.8396 3315201
Year 4 3250389 4598819 14621213 0.7921 2574613
TOTAL 14621213 12680500




The Net Present Value at 6% discount rate is 2658106

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Net Present Value
2. Profitability Index
3. Internal Rate of Return
4. Payback Period

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Prayas Sanofi have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Prayas Sanofi shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.






Formula and Steps to Calculate Net Present Value (NPV) of Prayas by Sanofi-Aventis in India: Making Healthcare Accessible to the Bottom of the Pyramid

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Strategy & Execution Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Prayas Sanofi often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Prayas Sanofi needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10022394) -10022394 - -
Year 1 3460814 -6561580 3460814 0.8696 3009403
Year 2 3961552 -2600028 7422366 0.7561 2995502
Year 3 3948458 1348430 11370824 0.6575 2596175
Year 4 3250389 4598819 14621213 0.5718 1858420
TOTAL 10459502


The Net NPV after 4 years is 437108

(10459502 - 10022394 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10022394) -10022394 - -
Year 1 3460814 -6561580 3460814 0.8333 2884012
Year 2 3961552 -2600028 7422366 0.6944 2751078
Year 3 3948458 1348430 11370824 0.5787 2284987
Year 4 3250389 4598819 14621213 0.4823 1567510
TOTAL 9487587


The Net NPV after 4 years is -534807

At 20% discount rate the NPV is negative (9487587 - 10022394 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Prayas Sanofi to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Prayas Sanofi has a NPV value higher than Zero then finance managers at Prayas Sanofi can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Prayas Sanofi, then the stock price of the Prayas Sanofi should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Prayas Sanofi should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What will be a multi year spillover effect of various taxation regulations.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What can impact the cash flow of the project.

Understanding of risks involved in the project.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Prayas by Sanofi-Aventis in India: Making Healthcare Accessible to the Bottom of the Pyramid

References & Further Readings

Harit Palan, Anand Kumar Jaiswal, Jagdip Singh, Garima Sharma (2018), "Prayas by Sanofi-Aventis in India: Making Healthcare Accessible to the Bottom of the Pyramid Harvard Business Review Case Study. Published by HBR Publications.


REMED SWOT Analysis / TOWS Matrix

Healthcare , Medical Equipment & Supplies


Intl Container A SWOT Analysis / TOWS Matrix

Consumer Cyclical , Auto & Truck Manufacturers


Kokuyo Camlin Ltd SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Office Supplies


Skyworks SWOT Analysis / TOWS Matrix

Technology , Semiconductors


Liberty Global SWOT Analysis / TOWS Matrix

Services , Broadcasting & Cable TV


Orange SWOT Analysis / TOWS Matrix

Services , Communications Services


S&U SWOT Analysis / TOWS Matrix

Financial , Consumer Financial Services


Shinyei Kaisha SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing